| anti-Nipah_019 | N-(1,3-benzodioxol-5-ylmethyl)-2-(3-cyano-2-methyl-1H-indol-1-yl)acetamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 39.55 % | 24501399 |
| anti-Nipah_020 | N-benzyl-6-phenyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine hydrochloride | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 102.26 % | 24501399 |
| anti-Nipah_021 | 9H-carbazol-3-amine | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 55.68 % | 24501399 |
| anti-Nipah_022 | 7-(1H-benzimidazol-2-ylthio)-8-methyl[1,3]dioxolo[4,5-g]quinolin-6(5H)-one | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 63.7 % | 24501399 |
| anti-Nipah_023 | N-[2-(2-methoxyethyl)-1,2,3,4-tetrahydropyrazino[1,2-a]benzimidazol-8-yl]benzamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 16 % | 24501399 |
| anti-Nipah_024 | tris[4-(dimethylamino)phenyl]methanol | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 121.65 % | 24501399 |
| anti-Nipah_025 | 6-chloro-N-[3-(4-methyl-1H-pyrazol-1-yl)propyl]-2-(3-pyridinyl)-4-quinolinecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 94.08 % | 24501399 |
| anti-Nipah_026 | 1-(2-furoyl)-5-(2-furyl)-3-(3-methoxyphenyl)-4,5-dihydro-1H-pyrazole | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 5.15 % | 24501399 |
| anti-Nipah_027 | 2-[(1H-benzimidazol-2-ylmethyl)thio]-1-[2-(4-methylphenoxy)ethyl]-1H-benzimidazole | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 23.57 % | 24501399 |
| anti-Nipah_028 | N-(3-chloro-4-fluorophenyl)-N-[4-(4-morpholinylsulfonyl)phenyl]urea | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 53.73 % | 24501399 |
| anti-Nipah_029 | 4-{[(5-methyl-2-thienyl)methyl]amino}phenol | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 15.92 % | 24501399 |
| anti-Nipah_030 | N-[5-(1H-benzimidazol-2-yl)-2-methylphenyl]-1,3-benzodioxole-5-carboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 51.07 % | 24501399 |
| anti-Nipah_031 | N-[1-benzyl-2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]benzamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 16.58 % | 24501399 |
| anti-Nipah_032 | 2-methoxy-N-[1-methyl-2-(1-pyrrolidinylmethyl)-1H-benzimidazol-5-yl]benzamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 6.45 % | 24501399 |
| anti-Nipah_033 | N-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)-2-(2-naphthyloxy)acetamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 80.96 % | 24501399 |
| anti-Nipah_034 | N-(2,5-dimethoxyphenyl)-N-[4-(trifluoromethyl)phenyl]urea | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 40.8 % | 24501399 |
| anti-Nipah_035 | 4-{[(1H-benzimidazol-2-ylthio)acetyl]amino}phenyl thiocyanate | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 31.81 % | 24501399 |
| anti-Nipah_036 | N-(3,4-dichlorophenyl)-N-[3-(trifluoromethyl)phenyl]urea | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 44.08 % | 24501399 |
| anti-Nipah_037 | N-1,3-benzodioxol-5-yl-6-chloro-2-(3-pyridinyl)-4-quinolinecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 55.7 % | 24501399 |
| anti-Nipah_038 | N-(3-chlorophenyl)-N-(4-cyanophenyl)urea | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 63.91 % | 24501399 |
| anti-Nipah_039 | N-[4-(1H-benzimidazol-2-yl)phenyl]-2-chloro-5-(4H-1,2,4-triazol-4-yl)benzamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 27.96 % | 24501399 |
| anti-Nipah_040 | N-[3-(aminocarbonyl)-5-benzyl-2-thienyl]-2-methyl-3-furamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 18.33 % | 24501399 |
| anti-Nipah_041 | 4,5-dimethyl-2-{[(5-propyl-3-thienyl)carbonyl]amino}-N-(3-pyridinylmethyl)-3-thiophenecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 12.33 % | 24501399 |
| anti-Nipah_042 | 1-(isopropylamino)-3-(3-phenyl-4,5-dihydropyrazolo[4,3-a]carbazol-10(3H)-yl)-2-propanol | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 49.78 % | 24501399 |
| anti-Nipah_043 | 2-[(4-tert-butyl-1,3-thiazol-2-yl)amino]-8-quinolinol | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 2.06 % | 24501399 |
| anti-Nipah_044 | N-(aminocarbonyl)-2-{[(5-methyl-3-thienyl)carbonyl]amino}-3-thiophenecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 46.11 % | 24501399 |
| anti-Nipah_045 | 2-chloro-N-(4-phenyl-1,3-thiazol-2-yl)-5-(4H-1,2,4-triazol-4-yl)benzamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 81.01 % | 24501399 |
| anti-Nipah_046 | N-[3-(2-oxo-2H-chromen-3-yl)phenyl]-1,3-benzodioxole-5-carboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 58.07 % | 24501399 |
| anti-Nipah_047 | 4,5-dimethyl-2-[(phenoxyacetyl)amino]-N-(3-pyridinylmethyl)-3-thiophenecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 55.23 % | 24501399 |
| anti-Nipah_048 | N-(4-{[(5-methyl-3-isoxazolyl)amino]sulfonyl}phenyl)-1-benzothiophene-3-carboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 45.06 % | 24501399 |
| anti-Nipah_049 | 3-[(1H-benzimidazol-2-ylmethyl)thio]-9-benzyl-9H-[1,2,4]triazolo[4,3-a]benzimidazole | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 12.87 % | 24501399 |
| anti-Nipah_050 | methyl N-[4,6-bis(isopropylamino)-1,3,5-triazin-2-yl]-N-cyanoglycinate | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 88.36 % | 24501399 |
| anti-Nipah_051 | N-(3,4-dichlorophenyl)-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 57.76 % | 24501399 |
| anti-Nipah_052 | N-(3-pyridinylmethyl)dibenzo[b,d]furan-3-amine | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 31.98 % | 24501399 |
| anti-Nipah_053 | (1,3-benzodioxol-5-ylmethyl)[4-(1-pyrrolidinyl)phenyl]amine | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | -8.16 % | 24501399 |
| anti-Nipah_054 | 4-methyl-5-phenyl-N-3-pyridinyl-2-thiophenecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 49.25 % | 24501399 |
| anti-Nipah_055 | N-(2,5-dimethoxyphenyl)-2-(2-oxo-1,3-benzoxazol-3(2H)-yl)acetamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 30.96 % | 24501399 |
| anti-Nipah_056 | 3-[(2,4-dichlorophenoxy)methyl]-N-(3-pyridinylmethyl)benzamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 39.35 % | 24501399 |
| anti-Nipah_057 | 5-phenyl-2-(2-phenylethyl)[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 30.39 % | 24501399 |
| anti-Nipah_058 | 6-bromo-2-oxo-N-3-pyridinyl-2H-chromene-3-carboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 97.85 % | 24501399 |
| anti-Nipah_059 | 2-[(2-methyl-8-quinolinyl)amino]-4H-pyrido[3,2-e][1,3]thiazin-4-one | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 9.77 % | 24501399 |
| anti-Nipah_060 | N-(3-chloro-4-fluorophenyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]urea | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 42.76 % | 24501399 |
| anti-Nipah_061 | 4-({[(3-chloro-4-fluorophenyl)amino]carbonyl}amino)-N-methylbenzenesulfonamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 41.82 % | 24501399 |
| anti-Nipah_062 | 2-(4-fluorophenyl)-N-(4-{[(4-methylphenyl)amino]sulfonyl}phenyl)acetamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 27.2 % | 24501399 |
| anti-Nipah_063 | 5-methyl-N-[4-(1-pyrrolidinylsulfonyl)phenyl]-3-thiophenecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | -11.7 % | 24501399 |
| anti-Nipah_064 | 2-amino-N-(3-chlorophenyl)-3-quinolinecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 46.45 % | 24501399 |
| anti-Nipah_065 | 2-(1,3-benzodioxol-5-yl)-1-(1,3-benzodioxol-5-ylmethyl)-1H-benzimidazole | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 13.74 % | 24501399 |
| anti-Nipah_066 | N-{3-[(benzylamino)carbonyl]phenyl}-5-methyl-3-thiophenecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 15.09 % | 24501399 |
| anti-Nipah_067 | 8-chloro-N-[3-(3-methyl-1H-pyrazol-1-yl)propyl]-2-(2-pyridinyl)-4-quinolinecarboxamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | -0.5 % | 24501399 |
| anti-Nipah_068 | N-[4-(2,4-difluorophenyl)-1,3-thiazol-2-yl]-2-(2-thienyl)acetamide | Nipah virus Peptide -F0, amino acids 105 to 114 | CatL-Peptide cleavage | Percentage inhibition | 12.4 % | 24501399 |